Monitoring of Adults with Diagnosed Diabetes
MEPS Statistical Brief #518
Treatment and Monitoring of Adults with Diagnosed Diabetes by Race/Ethnicity, a statistical brief from the Medical Expenditure Panel Survey-Household Component, presents estimates of the prevalence of reported diagnoses of diabetes for adults age 18 and older by race/ethnicity, and then focuses on differences among racial/ethnic groups in treatment and monitoring of the condition.
The treatment methods considered include insulin injection, oral medications, and diet modification. Monitoring services by a health professional include blood cholesterol check, checking of feet for sores or irritations, eye exam with dilation, and blood check for hemoglobin A1C.
- In 2015-16, black adults had a higher average annual prevalence of diagnosed diabetes (i.e., ever being told by a doctor or health professional that they had diabetes) than other racial/ethnic groups.
- Asian adults with diabetes were less likely than their counterparts in other racial/ethnic categories to be treated with insulin injections and more likely to rely on oral medications and diet modification to control the condition.
- White adults with diabetes were generally more likely than their minority counterparts to report having received the recommended monitoring tests examined in this brief (blood cholesterol testing, foot exam, eye exam, and A1C testing) during the year.
- High rates of substance-related stays contributed to costs:
- Alcohol-related stays in Rhode Island and Massachusetts (80 and 71 percent of counties in the top quintile) cost an average of $98 and $95 per resident annually, respectively.
- Opioid-related stays in West Virginia and Massachusetts (66 and 64 percent of counties in the top quintile) cost $33 and $39 per resident annually, respectively.
- Stimulant-related stays in California and North Carolina (63 and 56 percent of counties in the top quintile) cost $32 and $15 per resident annually, respectively.
Page originally created December 2018